SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-009590
Filing Date
2024-03-27
Accepted
2024-03-27 16:07:20
Documents
15
Period of Report
2024-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20240326_8k.htm   iXBRL 8-K 27207
2 EXHIBIT 99.1 ex_645762.htm EX-99.1 97237
  Complete submission text file 0001437749-24-009590.txt   284872

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20240327.xsd EX-101.SCH 3849
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20240327_def.xml EX-101.DEF 13380
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20240327_lab.xml EX-101.LAB 17544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20240327_pre.xml EX-101.PRE 13357
18 EXTRACTED XBRL INSTANCE DOCUMENT bcda20240326_8k_htm.xml XML 4632
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 24790634
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)